Stage IIIC Colorectal Cancer AJCC v7 Recruiting Phase 2 Trials for Capecitabine (DB01101)

Indication	Status	Phase
DBCOND0090390 (Stage IIIC Colorectal Cancer AJCC v7)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03396926	Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Pembrolizumab (DB09037)